Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates

Rajagopalan, S., Rourke, A. K., Asare, E., Kohlerschmidt, D. J., Das, L., Ngema, S. L., Mulholland, C. V., Vilchèze, C., Mahalingam, V., Moodley, S., Truebody, B., Mackenzie, J., Steyn, A. J. C., Perumal, R., Berney, M., Larsen, M. H., O’Donnell, M. R., Escuyer, V. E., & Jacobs, W. R. (2024). Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae438
Authors:
Saranathan Rajagopalan
Amy K Rourke
Emmanuel Asare
Donna J Kohlerschmidt
Lahari Das
Senamile L Ngema
Claire V Mulholland
Catherine Vilchèze
Vaishnavi Mahalingam
Sashen Moodley
Barry Truebody
Jared Mackenzie
Adrie J C Steyn
Rubeshan Perumal
Michael Berney
Michelle H Larsen
Max R O'Donnell
Vincent E Escuyer
William R Jacobs
Affiliated Authors:
Max R O'Donnell
Author Keywords:
mycobacterium tuberculosis
bedaquiline
drug susceptibility testing
mycobacteriophage
rifampicin
Publication Type:
Article
Unique ID:
10.1093/infdis/jiae438
PMID:
Publication Date:
Data Source:
PubMed

Record Created: